Reports FY23 revenue $31.02M, consensus $36.94M.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CTSO:
- CytoSorbents Reports Fourth Quarter and Full Year 2023 Results
- Cytosorbents Corp (CTSO) Q4 Earnings Cheat Sheet
- CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference
- Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients
- CytoSorbents reports outcomes from RCT using CytoSorb blood purification